Tanios Bekaii-Saab
机构: Mayo Clinic Cancer Center
每年引用次数
引用次数
引用: 24,807
H-指数: 76
I10-指数 : 316
出版物: 956
Integrating anti-EGFR therapies in metastatic colorectal cancer
Sigurdis Haraldsdottir , Tanios Bekaii-Saab
Journal of gastrointestinal oncology 4 ( 3) 285 -298
19
2013
A phase II study of biweekly pralatrexate and docetaxel in patients with advanced esophageal and gastroesophageal carcinoma that have failed first-line platinum-based therapy
Melissa Yereb , Christina Wu , Lai Wei , Jeffrey Rose
Journal of gastrointestinal oncology 6 ( 3) 336 -340
2
2015
K-ras Testing and Its Implications In the Treatment of Metastatic Colorectal Cancer
Tanios Bekaii-Saab
2009
Expanding the arsenal for metastatic colorectal cancer: a discussion of current clinical trials.
Tanios Bekaii-Saab
Clinical advances in hematology & oncology 7 ( 7) 430 -432
2009
Stellate cells as mediators of immune suppressive features in pancreatic cancer
Christopher William McQuinn , Thomas A Mace , Matthew R Farren , Hannah Komar
Journal of Immunology 196
2016
Recent advances in the treatment of pancreatic adenocarcinoma: Further observations
Ramesh K. Ramanathan , Tanios Bekaii-Saab
Clinical advances in hematology & oncology 15 ( 11)
2017
Recent advances in the treatment of pancreatic adenocarcinoma
Fadi Braiteh , Tanios Bekaii-Saab , Ramesk K Ramanathan
Clinical advances in hematology & oncology 15 ( 11) 1 -2
4
2017
New frontiers and therapeutic advances for metastatic adenocarcinoma and pancreatic neuroendocrine tumors: Q&A
George P. Kim , Alok A. Khorana , Tanios Bekaii-Saab
Clinical advances in hematology & oncology 15 ( 12) 21 -22
2017
Advancing the treatment frontiers for metastatic pancreatic adenocarcinoma and panNETs
Tanios Bekaii-Saab
Clinical advances in hematology & oncology 15 ( 12) 16 -20
2017
Advances in the management of pancreatic adenocarcinoma: Guidelines and clinical practice
Tanios Bekaii-Saab
Clinical advances in hematology & oncology 15 ( 11) 11 -14
2017
Authors' reply to letter to editor: Confusion solved; sort of
Sherif Abdel-Misih , Tanios Bekaii-Saab
Journal of The National Comprehensive Cancer Network 15 ( 8) 975 -976
2017
Human pd1 peptide vaccines and uses thereof
Tanios Bekaii-Saab , Pravin T.P. Kaumaya
2018
A treatment landscape in evolution: new strategies, guidelines, and therapeutic advances for metastatic pancreatic adenocarcinoma.
Tanios Bekaii-Saab
Clinical advances in hematology & oncology 16 ( 9) 5 -7
2018
Highlights in pancreatic cancer from the 2018 American Society of Clinical Oncology Gastrointestinal Cancers Symposium: commentary.
Tanios Bekaii-Saab
Clinical advances in hematology & oncology 16 ( 3) 16 -18
2018
A closer look at regorafenib.
Tanios Bekaii-Saab
Clinical advances in hematology & oncology 16 ( 10) 667 -669
1
2018
New guideline-sanctioned and emerging interventions for pancreatic cancer.
Tanios Bekaii-Saab
Clinical advances in hematology & oncology 16 ( 9) 7 -9
2018
Sequencing beyond the second-line setting in metastatic colorectal cancer.
John L. Marshall , Tanios Bekaii-Saab , Axel F Grothey
Clinical advances in hematology & oncology 17 ( 3) 1 -19
4
2019
Clinical Trial Data for Third-Line Therapy in Metastatic Colorectal Cancer.
Tanios Bekaii-Saab
Clinical advances in hematology & oncology 17 ( 3) 5 -13
2019
How I treat metastatic colorectal cancer.
Tanios Bekaii-Saab
Clinical advances in hematology & oncology 16 ( 9) 2 -6
2018
Sequencing beyond the second-line setting in metastatic colorectal cancer: further observations.
John L. Marshall , Tanios Bekaii-Saab , Axel F Grothey
Clinical advances in hematology & oncology 17 ( 3) 16 -18
2019